Acetamide, 2-amino-N-[5-[6-chloro-5-[[[4-(1,1-dimethylethyl)phenyl]sulfonyl]amino]-3-pyridinyl]-4-methyl-2-thiazolyl]- manufacturers
- PI3KD/V-IN-01
-
- $2500.00
-
2026-04-20
- CAS:1807551-44-5
- Purity:
- Supply Ability: 10g
|
| | Acetamide, 2-amino-N-[5-[6-chloro-5-[[[4-(1,1-dimethylethyl)phenyl]sulfonyl]amino]-3-pyridinyl]-4-methyl-2-thiazolyl]- Basic information |
| | Acetamide, 2-amino-N-[5-[6-chloro-5-[[[4-(1,1-dimethylethyl)phenyl]sulfonyl]amino]-3-pyridinyl]-4-methyl-2-thiazolyl]- Chemical Properties |
| density | 1.405±0.06 g/cm3(Predicted) | | pka | 6.30±0.50(Predicted) |
| | Acetamide, 2-amino-N-[5-[6-chloro-5-[[[4-(1,1-dimethylethyl)phenyl]sulfonyl]amino]-3-pyridinyl]-4-methyl-2-thiazolyl]- Usage And Synthesis |
| Description | PI3KD/V-IN-01 is a highly potent ATP-competitive PI3Kδ/Vps34 dual inhibitor. In cells, PI3KD/V-IN-01 showed 30-300 fold selectivity between PI3Kδ and other class I PI3K isoforms. PI3KD/V-IN-01 exhibited better anti-proliferative activity against AML, CLL and Burkitt lymphoma cell lines than known selective PI3Kδ and Vps34 inhibitors. | | Uses | PI3K-IN-12 (comp 76) is a PI3K inhibitor[1]. | | References | [1] NEW PI3K KINASE INHBITORS. Patent. WO2016101553A1. |
| | Acetamide, 2-amino-N-[5-[6-chloro-5-[[[4-(1,1-dimethylethyl)phenyl]sulfonyl]amino]-3-pyridinyl]-4-methyl-2-thiazolyl]- Preparation Products And Raw materials |
|